Demirer, T. Et Al. 2019. Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation.. JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15_suppl , 19532.

Demirer, T., Cengiz Seval, G., Toprak, S. K., Civriz Bozdag, S., Yuksel, M. K., Topcuoglu, P., ... Arslan, O.(2019). Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation.. JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15_suppl, 19532.

Demirer, TANER Et Al. "Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation.," JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15_suppl, 19532, 2019

Demirer, TANER Et Al. "Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation.." JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15_suppl, pp.19532, 2019

Demirer, T. Et Al. (2019) . "Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation.." JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15_suppl, p.19532.

@article{article, author={TANER DEMİRER Et Al. }, title={Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2019, pages={19532} }